SRPT vs. VTV

Last updated Jun 4, 2026

SRPT (Sarepta Therapeutics, Inc.) is a stock, while VTV (Vanguard Value ETF) is Large Cap Value Equities fund tracking the CRSP US Large Cap Value Index. Over the past 10 years, SRPT returned 0.42%/yr vs 12.49%/yr for VTV. At a 0.30 correlation, their price movements are largely independent.

Performance

SRPT vs. VTV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sarepta Therapeutics, Inc. (SRPT) and Vanguard Value ETF (VTV). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SRPT achieves a -24.54% return, which is significantly lower than VTV's 13.16% return. Over the past 10 years, SRPT has underperformed VTV with an annualized return of 0.42%, while VTV has yielded a comparatively higher 12.49% annualized return.

SRPT

• 1D: -0.06%
• 1M: -26.32%
• YTD: -24.54%
• 6M: -25.64%
• 1Y: -58.22%
• 3Y*: -49.37%
• 5Y*: -25.96%
• 10Y*: 0.42%

VTV

• 1D: 0.77%
• 1M: 4.08%
• YTD: 13.16%
• 6M: 14.00%
• 1Y: 27.88%
• 3Y*: 18.69%
• 5Y*: 11.41%
• 10Y*: 12.49%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SRPT vs. VTV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SRPT Sarepta Therapeutics, Inc.	-24.54%	-82.30%	26.09%	-25.58%	43.90%	-47.18%	32.12%	18.24%	96.14%	102.84%
VTV Vanguard Value ETF	13.16%	15.27%	15.95%	9.32%	-2.09%	26.53%	2.33%	25.66%	-5.47%	17.15%

Correlation

The correlation between SRPT and VTV is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.27
Correlation (3Y) Calculated over the trailing 3-year period	0.26
Correlation (5Y) Calculated over the trailing 5-year period	0.31
Correlation (10Y) Calculated over the trailing 10-year period	0.30
Correlation (All Time) Calculated using the full available price history since Feb 2, 2004	0.30

Return for Risk

SRPT vs. VTV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SRPT

SRPT Risk / Return Rank: 17
SRPT Sharpe Ratio Rank: 16
SRPT Sortino Ratio Rank: 22
SRPT Omega Ratio Rank: 21
SRPT Calmar Ratio Rank: 10
SRPT Martin Ratio Rank: 18

VTV

VTV Risk / Return Rank: 85
VTV Sharpe Ratio Rank: 85
VTV Sortino Ratio Rank: 88
VTV Omega Ratio Rank: 83
VTV Calmar Ratio Rank: 83
VTV Martin Ratio Rank: 83

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SRPT vs. VTV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sarepta Therapeutics, Inc. (SRPT) and Vanguard Value ETF (VTV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SRPT	VTV	Difference
Sharpe ratio: Return per unit of total volatility	-0.56	2.77	-3.34
Sortino ratio: Return per unit of downside risk	-0.36	3.95	-4.31
Omega ratio: Gain probability vs. loss probability	0.94	1.50	-0.55
Calmar ratio: Return relative to maximum drawdown	-0.81	4.41	-5.22
Martin ratio: Return relative to average drawdown	-1.08	16.67	-17.74
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SRPT vs. VTV - Sharpe Ratio Comparison

The current SRPT Sharpe Ratio is -0.56, which is lower than the VTV Sharpe Ratio of 2.77. The chart below compares the historical Sharpe Ratios of SRPT and VTV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	SRPT	VTV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.56	2.77	-3.34
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.37	0.83	-1.20
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.01	0.75	-0.75
Sharpe Ratio (All Time) Calculated using the full available price history	-0.03	0.51	-0.55

Drawdowns

SRPT vs. VTV - Drawdown Comparison

The maximum SRPT drawdown since its inception was -98.17%, which is greater than VTV's maximum drawdown of -59.27%. Use the drawdown chart below to compare losses from any high point for SRPT and VTV.

Drawdown Indicators

	SRPT	VTV	Difference
Max Drawdown Largest peak-to-trough decline	-98.17%	-59.27%	-38.90%
Max Drawdown (1Y) Largest decline over 1 year	-72.26%	-6.35%	-65.91%
Max Drawdown (3Y) Largest decline over 3 years	-92.72%	-14.52%	-78.20%
Max Drawdown (5Y) Largest decline over 5 years	-92.72%	-17.04%	-75.68%
Max Drawdown (10Y) Largest decline over 10 years	-93.33%	-36.78%	-56.55%
Current Drawdown Current decline from peak	-90.91%	0.00%	-90.91%
Average Drawdown Average peak-to-trough decline	-68.14%	-7.87%	-60.27%
Ulcer Index Depth and duration of drawdowns from previous peaks	54.00%	1.68%	+52.32%

Volatility

SRPT vs. VTV - Volatility Comparison

Sarepta Therapeutics, Inc. (SRPT) has a higher volatility of 17.02% compared to Vanguard Value ETF (VTV) at 2.48%. This indicates that SRPT's price experiences larger fluctuations and is considered to be riskier than VTV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SRPT	VTV	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.02%	2.48%	+14.54%
Volatility (6M) Calculated over the trailing 6-month period	52.59%	7.57%	+45.02%
Volatility (1Y) Calculated over the trailing 1-year period	103.50%	10.12%	+93.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	69.81%	13.88%	+55.93%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	70.75%	16.66%	+54.09%

Dividends

SRPT vs. VTV - Dividend Comparison

SRPT has not paid dividends to shareholders, while VTV's dividend yield for the trailing twelve months is around 1.85%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
SRPT Sarepta Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
VTV Vanguard Value ETF	1.85%	2.05%	2.31%	2.46%	2.52%	2.15%	2.56%	2.50%	2.73%	2.29%	2.44%	2.60%

Frequently Asked Questions

Can I hold both SRPT and VTV in my portfolio?

SRPT and VTV have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SRPT or VTV?

SRPT has higher volatility (17.02%) compared to VTV (2.48%). In terms of maximum drawdown, SRPT dropped -98.17% vs VTV's -59.27%.

Which has better risk-adjusted returns?

VTV currently has the higher Sharpe Ratio (2.77 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.